Trademark Attorney / Law Firm
Marco F. Garavaglia, Esq. – Trademark Portfolio
Marco F. Garavaglia, Esq. specializes in Class 35 (Advertising & Business) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 3 total filings concentrated in this category. The practice also covers Class 43 (Hotels & Restaurants) along with 3 other Nice Classification classes. Filing activity spans from 2013 to 2025. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Marco F. Garavaglia, Esq.'s trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Marco F. Garavaglia, Esq. filed?
Marco F. Garavaglia, Esq. has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Marco F. Garavaglia, Esq. specialize in?
Marco F. Garavaglia, Esq. has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 43 (Hotels & Restaurants), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
How long has Marco F. Garavaglia, Esq. been filing trademarks?
Marco F. Garavaglia, Esq.'s trademark filing history with the USPTO spans from 2013 to 2025, covering 12 years of trademark practice. During this period, Marco F. Garavaglia, Esq. has handled 3 trademark applications.
What is Marco F. Garavaglia, Esq.'s trademark registration success rate?
Marco F. Garavaglia, Esq. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.